🕒 : Open daily from 11:00 AM to 8:00 PM.

The Breakthrough Weight Loss Injection of 2025 – Tirzepatide (Mounjaro)

Lose up to 22.5% of your body weight with the most advanced dual-action injectable therapy.
Safe. Effective. Doctor-supervised.

Book a Free Consultation →
S 2351217

What is Tirzepatide?

Tirzepatide (brand name: Mounjaro) is a novel injectable medication developed by Eli Lilly. Initially designed for type 2 diabetes management, recent clinical trials have shown exceptional weight loss benefits, leading to FDA approval in late 2023 for obesity treatment. As of 2025, it is rapidly gaining global attention as one of the most powerful medical solutions for sustainable weight loss.
Get a Free Weight Loss Consultation →

How Does Tirzepatide Work?

Tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it mimics the actions of two natural gut hormones:

  • GIP (Glucose-dependent insulinotropic polypeptide)

  • GLP-1 (Glucagon-like peptide-1)

These hormones work synergistically to:

  • Suppress appetite

  • Slow gastric emptying (promoting prolonged satiety)

  • Enhance insulin secretion and suppress glucagon (helping regulate blood sugar)

Unlike Semaglutide (e.g., Ozempic or Wegovy), which activates only GLP-1 receptors, Tirzepatide targets both GLP-1 and GIP receptors, making it significantly more effective in metabolic regulation and weight reduction.

Is Tirzepatide Right for You? → Ask Us Now
ยกกระชับผิวหน้า

Efficacy in Weight Loss

S 2351229

SURMOUNT-1 trial (NEJM, 2022) demonstrated:

  • Tirzepatide 15 mg resulted in 22.5% average body weight reduction over 72 weeks.
  • In comparison, Semaglutide 2.4 mg achieved 14.9% reduction over 68 weeks (STEP-1, NEJM, 2021).

Medication

Average Weight Loss

Duration

Tirzepatide 15 mg

22.5%

72 weeks

Semaglutide 2.4 mg

14.9%

68 weeks

Tirzepatide therefore outperforms existing GLP-1 based therapies in both efficacy and clinical outcomes.

Key Benefits
  • Greater weight reduction than Semaglutide
  • Weekly injection (once per week)
  • Improves glucose control in diabetic and prediabetic patients
  • Multiple dosage tiers: 2.5, 5, 7.5, 10, 12.5, and 15 mg
  • Dual mechanism enhances metabolic effects beyond GLP-1 alone

Possible Side Effects
Tirzepatide is generally well-tolerated, with side effects similar to other GLP-1 agonists:

  • Nausea and vomiting
  • Bloating or constipation
  • Decreased appetite
  • Rare risk of pancreatitis
  • Mild hypoglycemia, especially if used with other diabetic medications
When Will I See Results?
  • Noticeable weight reduction can begin within 1–2 months
  • Peak results typically appear around month 9–12
  • A treatment course of at least 6–12 months is recommended for sustainable outcomes
Dosage & Titration
  • Start at 2.5 mg once weekly
  • Increase the dose every 4 weeks if tolerated
  • Target dose: 10–15 mg/week
  • Administered via subcutaneous injection
Free Weight Loss Consultation

Frequently Asked Questions (FAQ)

Q: Who is eligible for Tirzepatide?

A: Adults with a BMI ≥30, or ≥27 with obesity-related conditions (e.g., hypertension, diabetes, high cholesterol)

Q: Can I use it if I don’t have diabetes?

A: Yes. Tirzepatide is approved for chronic weight management even in non-diabetic individuals.

Q: Will I regain weight if I stop?

A: As with most weight loss treatments, stopping the medication without lifestyle support may lead to weight regain. A long-term plan is advised.

Q: How is it different from Semaglutide?

A: Tirzepatide provides higher weight loss, better metabolic outcomes, and improved patient satisfaction, thanks to its dual-action mechanism.

Q: What should I check before starting the medication?

A: Baseline blood tests (liver, kidney, glucose), ultrasound (if needed), and medical screening to rule out contraindications.
S 2351217

Summary

Tirzepatide (Mounjaro) stands as the most effective weight loss injection available in 2025, offering superior outcomes through dual hormone targeting. With its once-weekly dosing, adjustable strength, and substantial weight loss percentages, it is revolutionizing the field of metabolic medicine.
If you are considering safe, medically supervised weight management, 22 Square Clinic’s “Slim Boost Program” is now available. Schedule a consultation with our doctors to tailor your treatment plan today.

Book a Free Consultation
Talk to a Doctor — Free via LINE
🇸🇬 Exclusive Invitation

Reserve Your Consultation — 50% OFF

Professional advice. Personalized service.
Limited slots available for first-time clients

🇸🇬 Exclusive Invitation

Reserve Your Consultation — 50% OFF

Professional advice. Personalized service.
Limited slots available for first-time clients